Pharmacokinetics of free ertapenem in critically ill septic patients: Intermittent versus continuous infusion

Minerva Anestesiologica

Volumn 77, Issue 11, 2011, Pages 1058-1062

  Breilh, D ^a   Fleureau, C ^b   Gordien, J B ^a   Joanes Boyau, O ^b   Texier Maugein, J ^c   Rapaport, S ^b   Boselli, E ^d   Janvier, G ^b   Saux, M C ^a  

^a University Victor Segalen   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Ertapenem; Intensive care; Pharmacokinetics

Indexed keywords

ERTAPENEM;

ABDOMINAL INFECTION; ADULT; AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INTERMITTENT THERAPY; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTENSIVE CARE UNIT; KIDNEY FUNCTION; KLEBSIELLA OXYTOCA; LOADING DRUG DOSE; MALE; MAXIMUM PLASMA CONCENTRATION; PHARMACODYNAMICS; PROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; BACTERIA; BETA-LACTAMS; CRITICAL ILLNESS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; SEPSIS;

EID: 80355130220     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Keating GM, Perry CM. Ertapenem: a review of its use in the treatment of bacterial infections. Drugs 2005;65:2151-78.
2. Drusano GL. Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'. Nat Rev Microbiol 2004;2:289-300.
3. Brink AJ, Richards GA, Schillack V, Kiem S, Schentag J. Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis. Int J Antimicrob Agents 2009;33:432-6.
4. Majumdar AK, Musson DG, Birk KL, Kitchen CJ, Holland S, McCrea J et al. Pharmacokinetics of ertapenem in healthy young volunteers. Antimicrob Agents Chemother 2002;46:3506-11.
5. Petrosillo N, Drapeau CM, Agrafotis M, Falagas ME. Some current issues in the pharmacokinetics/pharmacodynamics of antimicrobials in intensive care. Minerva Anestesiol 2010;76:509-24.
6. Roberts JA, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 2009;37:840-51; quiz 59.
7. Gordien JB, Boselli E, Fleureau C, Allaouchiche B, Janvier G, Lalaude O et al. Determination of free ertapenem in plasma and bronchoalveolar lavage by high-performance liquid chromatography with ultraviolet detection. J Chro-matogr B Analyt Technol Biomed Life Sci 2006;830:218-23.
8. Nix DE, Majumdar AK, DiNubile MJ. Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians. J Antimicrob Chemother 2004;53(Suppl 2):ii23-8.
9. Boselli E, Breilh D, Djabarouti S, Bel JC, Saux MC, Allaouchiche B. Difusion of ertapenem into bone and synovial tissues. J Antimicrob Chemother 2007;60:893-6.
10. Boselli E, Breilh D, Saux MC, Gordien JB, Allaouchiche B. Pharmacokinetics and lung concentrations of ertapenem in patients with ventilator-associated pneumonia. Intensive Care Med 2006;32:2059-62.
11. Roberts JA, Lipman J, Blot S, Rello J. Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients? Curr Opin Crit Care 2008;14:390-6.
12. Mouton JW, Touzw DJ, Horrevorts AM, Vinks AA. Comparative pharmacokinetics of the carbapenems: clinical implications. Clin Pharmacokinet 2000;39:185-201.
13. Wexler HM. In vitro activity of ertapenem: review of recent studies. J Antimicrob Chemother 2004;53(Suppl 2):ii11-21.